FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35848811000001103: Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110882901000001116 Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110883001000001113 Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Is a Solifenacin 1mg/ml oral suspension sugar free true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has active ingredient Solifenacin true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has specific active ingredient Solifenacin succinate true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has excipient Butylated hydroxyanisole false Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Is a Vesicare true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) 150 ml Has AMP True Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start